Skip to main content
. 2011 Nov 17;11:76. doi: 10.1186/1471-2318-11-76

Table 1.

Characteristics of the participants and a comparison between participants with and without normal bowel function.

Characteristics All participants
n = 197
Participants with normal bowel function
n = 116
Participants with
altered bowel function
n = 81
Statistics
p-value
Age (years) 85.6 (SD 6.9) 85.1 (SD 7.1) 86.4 (SD 6.7) 0.18
Gender - female 74.6 71.6 79.0 0.25
Body mass index (kg/m2) (n = 183) 24.3 (SD 5.3) 24.9 (SD 5.3) 23.5 (SD 5.2) 0.07
Smoking: Current/Before/Never (n = 193) (%) 7.8%/16.1%/76.2% 10.4%/17.4%/72.2% 3.8%/14.1%/82.1% 0.07
Use of alcohol more than once a month (n = 193) 29 (15.0%) 14 (12.3%) 15 (19.0%) 0.22
Intake of liquids (glass/day) 9.0 (1.0-17.0) 9.0 (3.0-15.0) 8.0 (1.0-17.0) 0.01
Dietary fibre (g/day) (n = 195) 14.5 (3.7-41.0) 14.7 (4.6-41.0) 13.5 (3.7-30.3) 0.15
Katz: Activity of daily living1 1 (0-6) 1 (0-6) 1 (0-6) 0.31
Mobility: Bedridden/Walk indoors/Walk outdoors 105(53.3%)/54(27.4%)/
38(19.3%)
61(52.6%)/28(24.1%)
/27(23.3%)
44(54.3%)/26(32.1%)/11(13.6%) 0.36
MNA2 - score (n = 141) 20.0 (8.5-26.0) 20.8 (8.5-26.0) 18.0 (9.5-26.0) 0.05
Consistency of food (n = 196)
Mashed food/Bread without crust/Ordinary food
35(17.9%)/39(19.9%)
/122(62.2%)
15(12.9%)/20(17.2%)
/81(69.8%)
20(25.0%)/19(23.8%)
/41(51.3%)
0.007
Number of diseases (n = 196) 5.0 (1-15) 5.0 (1-15) 4.0 (0-11) 0.36
Heart diseases (n = 195) 86 (44.1%) 52 (45.2%) 34 (42.5%) 0.77
Thrombo-embolic disease (n = 195) 16 (8.2%) 6 (5.2%) 10 (12.5%) 0.11
Stroke (n = 195) 75 (38.5%) 44 (37.9%) 31 (39.2%) 0.88
Depression/anxiety (n = 196) 98 (50.0%) 65 (56.0%) 33 (41.3%) 0.06
Dementia (n = 196) 104 (53.1%) 58 (50.0%) 46 (57.5%) 0.31
Diabetes (both I and II) (n = 196) 22 (11.2%) 13 (11.2%) 9 (11.3%) 1.00
Parkinson's disease(n = 196) 11 (5.6%) 5 (4.3%) 3 (7.5%) 0.34
Hypothyroidism (n = 195) 8 (4.1%) 5 (4.3%) 3 (3.8%) 0.84
Rheumatoid arthritis (n = 196) 8 (4.1%) 2 (1.7%) 6 (7.5%) 0.04
Cancer (n = 191) 30 (15.7%) 24 (21.4%) 6 (7.6%) 0.01
Abdominal operation (n = 193) 30 (15.5%) 22 (19.6%) 8 (9.9%) 0.07
Number of drugs 6 (0-20) 6 (0-20) 5(0-17) 0.10
Antithrombotic agents (B01A) 104 (52.8%) 61 (52.6%) 43 (53.1%) 1.00
Iron preparations (B03A) 35 (17.8%) 23 (19.8%) 12 (14.8%) 0.45
Diuretics (C03) 88 (44.7%) 54 (46.6%) 34 (42.0%) 0.56
Calcium channel blockers (C08) 23 (11.7%) 13 (11.2%) 10 (12.3%) 0.83
Thyroid hormones (H03AA) 16 (8.1%) 10 (8.6%) 6 (7.4%) 0.80
Antibiotics (J01) 28 (14.2%) 19 (16.4%) 9 (11.1%) 0.41
NSAID (M01A) 14 (7.1%) 9 (7.8%) 5 (6.2%) 0.67
Opioids (N02A) 24 (12.2%) 14 (12.1%) 10 (12.3%) 1.00
Dopaminergic agents (N04B) 9 (4.6%) 2 (1.7%) 7 (8.6%) 0.02
Benzodiazepin derivatives (N05BA) 46 (21.8%) 32 (27.6%) 14 (13.6%) 0.02
Antidepressants (N06A) 85 (43.1%) 50 (43.1%) 35 (43.2%) 1.00
Drug with anticholinergic effect 15 (7.6%) 8 (6.9%) 7 (8.6%) 0.79
High dose of ≥1 laxatives 71 (40.1%) 41 (40.6%) 30 (39.5%) 1.00

1 Katz - Activity of daily living. (Index 0-6: 0 = Very dependent; 6 = Independent)

2 MNA = Mini nutritional assessment® (score 0-30: <17 malnourished, 17-23.5 at risk of malnutrition, 24-30 normal nutritional status)

n = number available for the analysis

The results are given as mean (SD), median (range) and number (%). There were no missing values for the use of drugs.